Couple of things to note from the financials.
earnings per share dropped from 1.7 cents to 1.2 cents
profit increased by $4,000 - not a startling figure
amortisation up $1.5m from previous year
These figures would effect the valuation but not the underlying potential of the Company.
That's my 2 bob's worth.
- Forums
- ASX - By Stock
- BGL
- 2012 guidance
2012 guidance, page-5
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BGL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.33 |
Change
-0.090(6.36%) |
Mkt cap ! $1.708B |
Open | High | Low | Value | Volume |
$1.36 | $1.37 | $1.30 | $7.954M | 5.987M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 48975 | $1.33 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.33 | 17503 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2721 | 1.330 |
17 | 55737 | 1.325 |
17 | 117881 | 1.320 |
17 | 190103 | 1.315 |
13 | 167662 | 1.310 |
Price($) | Vol. | No. |
---|---|---|
1.335 | 48238 | 27 |
1.340 | 162029 | 24 |
1.345 | 220225 | 15 |
1.350 | 45571 | 10 |
1.355 | 14612 | 3 |
Last trade - 14.04pm 12/11/2024 (20 minute delay) ? |
Featured News
BGL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online